RNS Number:2491J
ReGen Therapeutics PLC
26 March 2003

ReGen Therapeutics Plc
26 March 2003

Immediate Release

                             ReGen Therapeutics Plc

                            SUBSTANTIAL SHAREHOLDING


London, UK - 26 March 2003: ReGen Therapeutics Plc (the "Company") announces
that on 17 March 2003 it received notification from Peter Redvers Garrod that
following an acquisition of 1,000,000 ordinary shares of the Company on 13 March
2003 he is now beneficially interested in 4,826,500 ordinary shares of the
Company representing approximately 4.46% of the current issued share capital of
the Company.

Issued by:

Marshall Robinson Roe
Contact: Andrew Marshall                       Tel: 020 7489 2033



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLEAKDKADLDEFE